STEROIDOGENESIS INHIBITORS INTERNATIONAL INC
SB-2, EX-23.1, 2000-12-20
BUSINESS SERVICES, NEC
Previous: STEROIDOGENESIS INHIBITORS INTERNATIONAL INC, SB-2, EX-21, 2000-12-20
Next: STEROIDOGENESIS INHIBITORS INTERNATIONAL INC, SB-2, EX-23.2, 2000-12-20




                                  EXHIBIT 23.1


                       LAW OFFICES OF RICHARD ROSSI, P.A.
--------------------------------------------------------------------------------




                                December 19, 2000

STEROIDOGENESIS INHIBITORS INTERNATONAL, INC.
101 Convention Center Dr.
Suite 310
Las Vegas NV 89109

Re:   Steroidogenesis Inhibitors International, Inc. (the "Company")

Ladies and Gentlemen:

         You have  requested  our opinion with respect to the legality of shares
of the  Company's  common  stock (the  "Common  Stock"),  to be  included in the
Registration  Statement  to be  filed  with  the U.S.  Securities  and  Exchange
Commission  pursuant to the Securities Act of 1933, as amended (the  "Securities
Act"),  with relation to the requirements of Form SB-2 of the  Commission..  Any
terms not otherwise  defined herein shall have the meanings  ascribed to them in
the Registration Statement.

         We have  examined the original or copies of such records of the Company
as we deem  relevant  and  necessary  in our  discretion  and have  assumed  the
accuracy,  legality and due execution of same. In such examination, we have also
assumed  the  genuineness  of all  signatures  on  original  documents,  and the
conformity to original  documents of all copies  submitted to us as conformed or
photo static copies. As to various questions relating to such opinions,  we have
relied upon  statements  of  officials  and  representatives  of the Company and
others.

         Based on, and subject to the  foregoing,  we are of the  opinion  that,
when the shares of Common  Stock are issued and  delivered  as  described in the
Registration Statement, and the appropriate filing is made, the shares of Common
Stock will be duly and validly  issued,  and the Common Stock will be fully paid
and non-assessable.

         We hereby  consent to the  filing of this  opinion as an exhibit to the
Registration Statement. We also consent to the use of our name under the caption
"Legal  Matters"  in  the  Prospectus  constituting  part  of  the  Registration
Statement.  In giving such consent, we do not thereby admit that we are included
within the category of persons whose consent is required  under Section 7 of the
Securities  Act,  or the  rules and  regulations  promulgated  thereunder.  This
opinion is  expressly  limited in scope to the shares  which are to be expressly
covered  by the  referenced  Registration  Statement  and  does  not  cover  any
subsequent  issuances  of shares  and this  opinion is  limited  (we  express no
opinion with respect to the laws of any jurisdiction). We consent to your filing
this opinion with the Commission as an exhibit to the  Registration  Statement .
This opinion is based  representations to this firm, and upon our assumptions as
to application of the law and facts as of the date hereof.

Sincerely,

Richard Rossi, P.A.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission